Importantly, KDM4B knockout animals are phenotypically normal (15), indicating that the enzyme is not a general regulator of cellular proliferation and aberrant expression in BCa is acquired on cellular transformation, suggesting targeting KDM4B is potentially tumour specific. This evidence concerns the gene KDM4B and neoplasm.